BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 9783260)

  • 1. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay.
    Li L; Singh BR
    J Nat Toxins; 1998 Oct; 7(3):215-26. PubMed ID: 9783260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G.
    Rummel A; Karnath T; Henke T; Bigalke H; Binz T
    J Biol Chem; 2004 Jul; 279(29):30865-70. PubMed ID: 15123599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.
    Nishiki T; Tokuyama Y; Kamata Y; Nemoto Y; Yoshida A; Sato K; Sekiguchi M; Takahashi M; Kozaki S
    FEBS Lett; 1996 Jan; 378(3):253-7. PubMed ID: 8557112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
    Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
    Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.
    Nishiki T; Kamata Y; Nemoto Y; Omori A; Ito T; Takahashi M; Kozaki S
    J Biol Chem; 1994 Apr; 269(14):10498-503. PubMed ID: 8144634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
    Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M
    J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of the synaptosome-binding regions on botulinum neurotoxin B.
    Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
    Biochemistry; 2012 Jan; 51(1):316-28. PubMed ID: 22146011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
    Willjes G; Mahrhold S; Strotmeier J; Eichner T; Rummel A; Binz T
    Biochemistry; 2013 Jun; 52(22):3930-8. PubMed ID: 23647335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.
    Kozaki S; Kamata Y; Nishiki T; Kakinuma H; Maruyama H; Takahashi H; Karasawa T; Yamakawa K; Nakamura S
    Infect Immun; 1998 Oct; 66(10):4811-6. PubMed ID: 9746583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II.
    Zhou Y; Foss S; Lindo P; Sarkar H; Singh BR
    FEBS J; 2005 Jun; 272(11):2717-26. PubMed ID: 15943806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A
    Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R; Rummel A; Binz T; Brunger AT
    Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes.
    Gerona RR; Larsen EC; Kowalchyk JA; Martin TF
    J Biol Chem; 2000 Mar; 275(9):6328-36. PubMed ID: 10692432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.
    Flores A; Ramirez-Franco J; Desplantes R; Debreux K; Ferracci G; Wernert F; Blanchard MP; Maulet Y; Youssouf F; Sangiardi M; Iborra C; Popoff MR; Seagar M; Fantini J; Lévêque C; El Far O
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):18098-18108. PubMed ID: 31431523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M; Richards DA; Goodnough MC; Tepp WH; Johnson EA; Chapman ER
    J Cell Biol; 2003 Sep; 162(7):1293-303. PubMed ID: 14504267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.